Emergent BioSolutions (EBS) Other Operating Expenses (2018 - 2026)
Emergent BioSolutions (EBS) posted quarterly Other Operating Expenses of -$12.2 million for Q1 2025, down 118.97% quarter-over-quarter from $64.3 million in Q3 2024.
Emergent BioSolutions (EBS) Other Operating Expenses (2018 - 2026) Analysis & Trends
Emergent BioSolutions' Other Operating Expenses history runs 8 years deep, the most recent figure standing at -$12.2 million for Q1 2025.
- In Q1 2025, Other Operating Expenses changed N/A year-over-year to -$12.2 million; the TTM figure through Dec 2025 stood at -$12.2 million (down 150.21% YoY), while the FY2025 annual figure was -$12.2 million, down 150.21% from the prior year.
- Other Operating Expenses for Q1 2025 stood at -$12.2 million, down from $64.3 million in the prior quarter.
- The five-year high for Other Operating Expenses was $305.2 million in Q4 2021, with the low at -$40.0 million in Q2 2024.
- The 5-year median for Other Operating Expenses is $114.2 million (2021), against an average of $120.0 million.
- Peak annual rise in Other Operating Expenses reached 9285.71% in 2024, while the deepest fall reached 153.4% in 2024.
- Emergent BioSolutions' Other Operating Expenses stood at $305.2 million in 2021, then tumbled by 44.33% to $169.9 million in 2022, then slumped by 100.41% to -$700000.0 in 2023, then jumped by 9285.71% to $64.3 million in 2024, then tumbled by 118.97% to -$12.2 million in 2025.
- Business Quant data shows EBS's Other Operating Expenses at -$12.2 million in Q1 2025, $64.3 million in Q3 2024, and -$40.0 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.70 Mn |
| Mar 31, 2025 | -12.20 Mn |
| Sep 30, 2024 | 64.30 Mn |
| Jun 30, 2024 | -40.00 Mn |
| Sep 30, 2023 | -700,000.00 |
| Jun 30, 2023 | 74.90 Mn |
| Mar 31, 2023 | 169.90 Mn |
| Mar 31, 2022 | 169.90 Mn |
| Dec 31, 2021 | 305.20 Mn |
| Sep 30, 2021 | 232.00 Mn |
| Jun 30, 2021 | 242.90 Mn |
| Mar 31, 2021 | 114.20 Mn |
| Dec 31, 2020 | 196.30 Mn |
| Sep 30, 2020 | 164.00 Mn |
| Jun 30, 2020 | 144.80 Mn |
| Mar 31, 2020 | 91.70 Mn |
| Dec 31, 2019 | 147.60 Mn |
| Sep 30, 2019 | 122.70 Mn |
| Jun 30, 2019 | 115.50 Mn |
| Mar 31, 2019 | 106.30 Mn |